Loading...
Loading...
Among the 8 tracked institutional investors we monitor, CRSP (CRISPR Therapeutics AG) is held with a combined value of $1.39B across 28,967,914 shares. The largest holder is ARK Investment Management LLC with a position worth $538.19M (4.19% of their portfolio). VANGUARD GROUP INC opened a new position in the most recent quarter. 5 funds increased their holdings. 2 funds reduced their position.
Total Institutional Value
$1.39B
Total Shares Held
28,967,914
Institutional Holders
8
| # | Fund | Value↓ | Portfolio % | Change |
|---|---|---|---|---|
| 1 | ARK Investment Management LLC | $538.19M | 4.19% | +7.5% |
| 2 | BlackRock, Inc. | $365.34M | 0.01% | +2.3% |
| 3 | STATE STREET CORP | $189.45M | 0.01% | +6.1% |
| 4 | VANGUARD GROUP INC | $118.95M | 0.00% | New |
| 5 | FMR LLC | $92.98M | 0.00% | +0.0% |
| 6 | CITADEL ADVISORS LLC | $64.10M | 0.01% | -16.0% |
| 7 | MILLENNIUM MANAGEMENT LLC | $17.94M | 0.01% | +1137.0% |
| 8 | Point72 Asset Management, L.P. | $2.09M | 0.00% | -14.4% |
As of the latest SEC 13F filings, ARK Investment Management LLC is the largest institutional holder of CRSP with a position worth $538.19M, representing 4.19% of their portfolio. In total, 8 institutional investors hold CRSP with a combined value of $1.39B.
In the most recent quarter, 1 fund opened a new position in CRSP. Additionally, 5 increased their holdings and 2 reduced their positions.
Institutional investors hold $1.39B worth of CRSP stock across 8 positions. The largest institutional holder is ARK Investment Management LLC with $538.19M in holdings.
A 13F filing is a quarterly report required by the SEC from institutional investment managers with over $100 million in assets. It discloses their holdings in U.S. equities. For CRSP, these filings reveal which major funds are accumulating or reducing positions, providing insights into institutional sentiment.
Get notified when hedge funds change their CRSP positions.